glp-1 and cancer Long-term risk in users of agonists in Denmark: a nationwide emulated trial Glucagon-like peptide 1 receptor agonist
Description
TAP-dementia receives cofinancing from Avid Radiopharmaceuticals and Amprion
diabetes is often associated with a variety of comorbidities, and the potential indications for tirzepatide (e.g., nonalcoholic steatohepatitis, nephroprotection, and cerebroprotection) will be an important next step to address
Health insurance plans often do not cover medication for off-label uses
Among patients with pre-transplant diabetes, outcomes aligned with the main findings
Obviously that chart is small sample size, but CMG and MCD have traded roughly inline with (or a bit better) than the market over the past year
